Citadel Advisors »

Aquestive Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.6M 366k 4.26
2023-12-31 $373k 184k 2.02
2023-09-30 $35k 23k 1.53
2023-06-30 $21k 13k 1.65
2023-03-31 $20k 18k 1.14
2022-12-31 $49k 54k 0.90
2022-06-30 $79k 123k 0.64
2022-03-31 $164k 63k 2.62
2021-12-31 $846k 212k 4.00
2021-09-30 $657k 151k 4.36
2021-06-30 $297k 75k 3.96
2021-03-31 $924k 178k 5.20
2020-12-31 $745k 138k 5.38
2020-09-30 $630k 130k 4.86
2020-06-30 $315k 65k 4.84
2020-03-31 $23k 11k 2.17
2018-09-30 $451k 26k 17.49